| US renal data system 2016 annual data report: epidemiology of kidney disease in the United States R Saran, B Robinson, KC Abbott, LYC Agodoa, P Albertus, J Ayanian, ... American journal of kidney diseases 69 (3), A7-A8, 2017 | 5098 | 2017 |
| Acute kidney injury recovery pattern and subsequent risk of CKD: an analysis of veterans health administration data M Heung, DE Steffick, K Zivin, BW Gillespie, T Banerjee, C Hsu, NR Powe, ... American Journal of Kidney Diseases 67 (5), 742-752, 2016 | 337 | 2016 |
| Food insecurity, CKD, and subsequent ESRD in US adults T Banerjee, DC Crews, DE Wesson, S Dharmarajan, R Saran, ... American journal of kidney diseases 70 (1), 38-47, 2017 | 131 | 2017 |
| Exploring potential reasons for the temporal trend in dialysis-requiring AKI in the United States RK Hsu, CE McCulloch, M Heung, R Saran, VB Shahinian, ME Pavkov, ... Clinical Journal of the American Society of Nephrology 11 (1), 14-20, 2016 | 64 | 2016 |
| State-level awareness of chronic kidney disease in the US SH Dharmarajan, JL Bragg-Gresham, H Morgenstern, BW Gillespie, Y Li, ... American journal of preventive medicine 53 (3), 300-307, 2017 | 53 | 2017 |
| Electronic phenotyping of health outcomes of interest using a linked claims-electronic health record database: findings from a machine learning pilot project TB Gibson, MD Nguyen, T Burrell, F Yoon, J Wong, S Dharmarajan, ... Journal of the American Medical Informatics Association 28 (7), 1507-1517, 2021 | 17 | 2021 |
| Early antibody responses associated with survival in COVID19 patients ZH Zhou, S Dharmarajan, M Lehtimaki, SL Kirshner, S Kozlowski PLoS Pathogens 17 (7), e1009766, 2021 | 15 | 2021 |
| Measuring pharmacy performance in the area of medication adherence: addressing the issue of risk adjustment S Dharmarajan, JP Bentley, BF Banahan III, DS West-Strum Journal of Managed Care Pharmacy 20 (10), 1057-1068, 2014 | 14 | 2014 |
| Sample size estimation for case‐crossover studies S Dharmarajan, JY Lee, R Izem Statistics in Medicine 38 (6), 956-968, 2019 | 12 | 2019 |
| Complex modeling with detailed temporal predictors does not improve health records-based suicide risk prediction SM Shortreed, RL Walker, E Johnson, R Wellman, M Cruz, R Ziebell, ... NPJ digital medicine 6 (1), 47, 2023 | 10 | 2023 |
| Statistical consideration for fit-for-use real-world data to support regulatory decision making in drug development M Levenson, W He, L Chen, S Dharmarajan, R Izem, Z Meng, H Pang, ... Statistics in Biopharmaceutical Research 15 (3), 689-696, 2023 | 8 | 2023 |
| Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination ZH Zhou, MM Cortese, JL Fang, R Wood, DS Hummell, KA Risma, ... Vaccine 41 (28), 4183-4189, 2023 | 8 | 2023 |
| Evaluating center performance in the competing risks setting: Application to outcomes of wait-listed end-stage renal disease patients SH Dharmarajan, DE Schaubel, R Saran Biometrics 74 (1), 289-299, 2018 | 5 | 2018 |
| PHP90 Case-Mix Adjustment of Adherence-Based Pharmacy Quality Indicator Scores S Dharmarajan, BF Banahan, JP Bentley, D West-Strum Value in Health 15 (4), A29, 2012 | 2 | 2012 |
| PIH34 IMPLEMENTATION OF A STATE MEDICAID PRESCRIPTION CAP POLICY: IS THERE AN IMPACT ON BENEFICIARIES'MEDICAL SERVICES UTILIZATION AND COSTS? R Khanna, SH Dharmarajan, KD Null, JP Bentley, PF Pace, BF Banahan Value in Health 14 (3), A111, 2011 | 2 | 2011 |
| The Use of Machine Learning in Regulatory Drug Safety Evaluation D Zhang, J Song, S Dharmarajan, TH Jung, H Lee, Y Ma, R Zhang, ... Statistics in Biopharmaceutical Research 15 (3), 519-523, 2023 | 1 | 2023 |
| Assessment of fit-for-use real-world data sources and applications W He, Z Zhang, S Dharmarajan Real-World Evidence in Medical Product Development, 45-61, 2023 | 1 | 2023 |
| Weighted estimators of the complier average causal effect on restricted mean survival time with observed instrument–outcome confounders SH Dharmarajan, Y Li, D Lehmann, DE Schaubel Biometrical Journal 63 (4), 712-724, 2021 | 1 | 2021 |
| PMH2 RISK OF HOSPITALIZATION FOR PNEUMONIA ASSOCIATED WITH THE USE OF ATYPICAL VERSUS TYPICAL ANTIPSYCHOTICS IN A NATIONAL SAMPLE OF MEDICARE BENEFICIARIES SH Dharmarajan, Y Yang, AS Athavale, JP Bentley, KD Null, BF Banahan Value in Health 14 (3), A185, 2011 | 1 | 2011 |
| Dispensing pharmacy chains and direct anticoagulants: Potential associations with patient outcomes S Kozlowski, E Tworkoski, S Dharmarajan, N Flowers, A Kwist, ... Pharmacoepidemiology and Drug Safety 33 (2), e5749, 2024 | | 2024 |
